Tailored injunctive relief in life sciences patent cases
par Dr Paul England
Biosimilars – interchangeability/substitution and advertising
par plusieurs auteurs
SmPC 'carve out' limits marketing authorisation
Brexit and the life sciences sector: The UK Government's offer to the EU
par Dr Paul England
Brexit and the life sciences sector: what is the relevance of the transition (implementation) period?
par Dr Paul England
Brexit and the life sciences sector: guidelines for 'no deal'
Dutch competition authority ACM starts sector inquiry into anti-rheumatism drugs
par Bram Nijhof
Health Technology Assessment – The Commission’s proposal of a new Health Technology Assessment Regulation
New trade secrets law takes effect in UK
par Mark Owen et Louise Popple
Dutch Supreme Court ruling on claim interpretation in Resolution v AstraZeneca
par Eelco Bergsma
Synapse - law for life sciences - May 2018
par Dr Paul England et Rhys Bufton
GC finds Normon similar to Normosang for pharmaceuticals
par Louise Popple